These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 6190557
1. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data. Price LA, MacRae K, Hill BT. Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557 [Abstract] [Full Text] [Related]
2. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM. Cancer J Sci Am; 1997 Jun; 3(2):92-9. PubMed ID: 9099459 [Abstract] [Full Text] [Related]
3. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL. J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256 [Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx. Tichler T, Ramon Y, Rath P, Hendler S, Brenner HJ. Isr J Med Sci; 1988 Aug 01; 24(9-10):539-44. PubMed ID: 2462551 [Abstract] [Full Text] [Related]
5. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers. Woods RL, Stewart J, Fox RM, Tattersall MH. Cancer Treat Rep; 1979 Aug 01; 63(11-12):1997-9. PubMed ID: 93514 [Abstract] [Full Text] [Related]
6. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck. Raafat J, Oster MW. Cancer Treat Rep; 1980 Jan 01; 64(1):187-9. PubMed ID: 6155209 [Abstract] [Full Text] [Related]
7. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck. Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D. Eur J Surg Oncol; 1989 Dec 01; 15(6):568-74. PubMed ID: 2480922 [Abstract] [Full Text] [Related]
8. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH. Cancer Chemother Pharmacol; 2008 Dec 01; 63(1):9-17. PubMed ID: 18343925 [Abstract] [Full Text] [Related]
9. Combination of cis-platinum, oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck. Peppard SB, Al-Sarraf M, Powers WE, Loh JK, Weaver AW. Laryngoscope; 1980 Aug 01; 90(8 Pt 1):1273-80. PubMed ID: 6157067 [Abstract] [Full Text] [Related]
10. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study. King GW, Halpin JJ, Smith RE, Batley F, Schuller DE. Cancer Treat Rep; 1979 Aug 01; 63(11-12):1735-8. PubMed ID: 93508 [Abstract] [Full Text] [Related]
11. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Athanasiadis I, Taylor S, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS. Cancer; 1997 Feb 01; 79(3):588-94. PubMed ID: 9028372 [Abstract] [Full Text] [Related]
12. [Studies on a neo-adjuvant chemotherapy for head and neck cancer]. Inuyama Y, Mashino S, Fujii M, Tanaka J, Takaoka T, Kohno N, Horiuchi M. Gan To Kagaku Ryoho; 1983 Mar 01; 10(3):786-91. PubMed ID: 6192768 [Abstract] [Full Text] [Related]
13. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Katori H, Tsukuda M, Taguchi T. Cancer Chemother Pharmacol; 2007 May 01; 59(6):789-94. PubMed ID: 17053926 [Abstract] [Full Text] [Related]
14. Effective outpatient combination chemotherapy for advanced cancer of the head and neck. Chiuten D, Vogl SE, Kaplan BH, Greenwald E. Surg Gynecol Obstet; 1980 Nov 01; 151(5):659-62. PubMed ID: 6159692 [Abstract] [Full Text] [Related]
15. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity]. Watanabe N, Kaneko T, Fujitani S, Umeyama M, Nomura Y, Zusho H, Yamada Y, Nanba G, Asahina N, Sugio Y, Okamoto Y, Daida T, Tokumaru T. Gan To Kagaku Ryoho; 1999 Jan 01; 26(1):101-6. PubMed ID: 9987505 [Abstract] [Full Text] [Related]
16. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck. Lester EP, Kinnealey A, Matz GJ. Laryngoscope; 1979 Dec 01; 89(12):1921-9. PubMed ID: 92740 [Abstract] [Full Text] [Related]
17. Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck. Tannock I, Cummings B, Sorrenti V. Cancer Treat Rep; 1982 Jun 01; 66(6):1421-4. PubMed ID: 6177413 [Abstract] [Full Text] [Related]
18. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J. Arch Otolaryngol Head Neck Surg; 2004 Jul 01; 130(7):861-7. PubMed ID: 15262764 [Abstract] [Full Text] [Related]
19. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H. J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937 [Abstract] [Full Text] [Related]
20. Safe and effective combination chemotherapy without cis-platinum for squamous cell carcinomas of the head and neck. Price LA, Hill BT. Cancer Treat Rep; 1981 Dec 01; 65 Suppl 1():149-54. PubMed ID: 7198936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]